contravir.comHepion Pharmaceuticals

contravir.com Profile

contravir.com

Title:Hepion Pharmaceuticals

Description：Hepion Pharmaceuticals Nasdaq HEPA is a clinical stage biopharmaceutical company focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis NASH and chronic hepatitis virus infection HBV HCV HDV

Discover contravir.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site

contravir.com Information

Website / Domain:	contravir.com
HomePage size:	80.198 KB
Page Load Time:	0.167163 Seconds
Website IP Address:	104.198.5.36
Isp Server:	Google Inc.

contravir.com Ip Information

Ip Country:	United States
City Name:	Mountain View
Latitude:	37.405990600586
Longitude:	-122.07851409912

contravir.com Keywords accounting

Keyword	Count

contravir.com Httpheader

Server: nginx
Date: Mon, 17 Feb 2020 07:20:26 GMT
Content-Type: text/html; charset=UTF-8
Transfer-Encoding: chunked
Connection: keep-alive
Keep-Alive: timeout=20
Vary: Accept-Encoding, Accept-Encoding,Cookie
X-Pingback: https://hepionpharma.com/xmlrpc.php
Link: https://hepionpharma.com/wp-json/; rel="https://api.w.org/", https://hepionpharma.com/; rel=shortlink
X-Powered-By: WP Engine
X-Cacheable: SHORT
Cache-Control: max-age=600, must-revalidate
X-Cache: HIT: 2
X-Pass-Why:
X-Cache-Group: normal
Content-Encoding: gzip

contravir.com Meta Info

charset="utf-8"/
content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=0" name="viewport"
content="Powered by WPBakery Page Builder - drag and drop page builder for WordPress." name="generator"/
content="https://hepionpharma.com/wp-content/uploads/2019/09/cropped-Hepion-Favicon-270x270.png" name="msapplication-TileImage"/

104.198.5.36 Domains

Domain	WebSite Title

contravir.com Similar Website

Domain	WebSite Title
contravir.com	Hepion Pharmaceuticals
zuchepharma.trustpass.alibaba.com	ZUCHE PHARMACEUTICALS PRIVATE LIMITED - Pharmaceuticals,Medical Devices
aeriepharma.com	Aerie Pharmaceuticals \| Leading Ophthalmic Pharmaceuticals
lifelinepharm.tracktracerx.com	Lifeline Pharmaceuticals, LLCâs Login Page \| Lifeline Pharmaceuticals, LLC
shop.neilmed.com	Welcome - NeilMed Pharmaceuticals, Inc.
titanpharm.com	About Titan Pharmaceuticals Titan Pharmaceuticals Inc
www1.actelion.us	Actelion Pharmaceuticals US, Inc
support.sppirx.com	Spectrum Pharmaceuticals, Inc.
avadel.com	Avadel Pharmaceuticals
akorn.com	Akorn Pharmaceuticals
pharma.bayer.com	Home \| Pharmaceuticals
inovio.com	INOVIO Pharmaceuticals
investor.cyclacel.com	Overview \| Cyclacel Pharmaceuticals, Inc.
investor.ironwoodpharma.com	Ironwood Pharmaceuticals, Inc. - Home
ir.syndax.com	Investors \| Syndax Pharmaceuticals, Inc.

contravir.com Traffic Sources Chart

contravir.com Alexa Rank History Chart

contravir.com Html To Plain Text

Hit enter to search or ESC to close Home About Company Overview Executive Team Cyclophilin Expertise Board of Directors Scientific Advisory Board Partnering Liver Disease Overview Non-alcoholic Steatohepatitis (NASH) Hepatocellular Carcinoma (HCC) Viral Hepatitis Pipeline Overview CRV431 Therapeutic Strategy Clinical Trials Publications Newsroom Investors Investor Overview Press Releases Events Presentations Company Information Stock Information SEC Filings Corporate Governance Contact Contact Us Careers TACKLING CHRONIC LIVER DISEASE TACKLING CHRONIC LIVER DISEASE BROAD SPECTRUM LIVER THERAPY NASH, hepatitis, cirrhosis, liver failure, cancer. Half a billion people worldwide are at risk unless new therapies are found. About (Nasdaq: HEPA) is a clinical stage biopharmaceutical company focused on the development of targeted therapies for liver disease arising from non-alcoholic steatohepatitis (NASH) and chronic hepatitis virus infection (HBV, HCV, HDV). The Company’s lead drug candidate, CRV431, reduces liver fibrosis and hepatocellular carcinoma tumor burden in experimental models of NASH. Currently in clinical phase development, CRV431 shows potential to play an important role in the overall treatment of liver disease – from triggering events through to end-stage disease. Company Overview Leadership Partnering Investors Recent News Stock Information Pipeline CRV431 Strategy Contact Us Careers News Alerts Recent News Announces Advancement to Third Dose Level in Ongoing Multiple Ascending Dose Clinical Study of CRV431 February 12, 2020 Hepion’s NASH Drug Candidate, CRV431, Demonstrates Superior Antifibrotic Efficacy in Expanded Human Liver Study January 28, 2020 Presents Update on CRV431 Nonclinical Studies at NASH-TAG 2020 Conference January 8, 2020 View Newsroom Get Important News and Updates by Email Subscribe © 2020 | Disclaimer & Terms of Use | WDDI Home About Company Overview Executive Team Cyclophilin Expertise Board of Directors Scientific Advisory Board Partnering Liver Disease Overview Non-alcoholic Steatohepatitis (NASH) Hepatocellular Carcinoma (HCC) Viral Hepatitis Pipeline Overview CRV431 Therapeutic Strategy Clinical Trials Publications Newsroom Investors Investor Overview Press Releases Events Presentations Company Information Stock Information SEC Filings Corporate Governance Contact Contact Us Careers...

contravir.com Whois

"domain_name": [ "CONTRAVIR.COM", "contravir.com" ], "registrar": "GoDaddy.com, LLC", "whois_server": "whois.godaddy.com", "referral_url": null, "updated_date": [ "2019-01-23 14:26:54", "2019-01-23 14:26:52" ], "creation_date": "2013-05-16 02:46:43", "expiration_date": "2024-05-16 02:46:43", "name_servers": [ "NS01.DOMAINCONTROL.COM", "NS02.DOMAINCONTROL.COM" ], "status": [ "clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited", "clientRenewProhibited https://icann.org/epp#clientRenewProhibited", "clientTransferProhibited https://icann.org/epp#clientTransferProhibited", "clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited", "clientTransferProhibited http://www.icann.org/epp#clientTransferProhibited", "clientUpdateProhibited http://www.icann.org/epp#clientUpdateProhibited", "clientRenewProhibited http://www.icann.org/epp#clientRenewProhibited", "clientDeleteProhibited http://www.icann.org/epp#clientDeleteProhibited" ], "emails": "abuse@godaddy.com", "dnssec": "unsigned", "name": null, "org": "ContraVir Pharmaceuticals, Inc", "address": null, "city": null, "state": "New Jersey", "zipcode": null, "country": "US"